Suchergebnisse - (Subject:"Siltuximab")

PubPharm (121)

81

Siltuximab (CNTO 328) : a promising option for human malignancies

enthalten in: Drug design, development and therapy | 2015

von Chen, R. | Chen, B.

82

Siltuximab for multicentric Castleman disease

enthalten in: Expert review of hematology | 2014

von Liu, Y. | Stone, K. | van Rhee, F.

83

A phase 2, randomized, double-blind, multicenter study comparing siltuximab plus best supportive care (BSC) with placebo plus BSC in anemic patients with International Prognostic Scoring System low- or intermediate-1-risk myelodysplastic syndrome

enthalten in: American journal of hematology | 2014

von Garcia-Manero, G. | Gartenberg, G. | Steensma, D. | +7

84

Siltuximab for multicentric Castleman's disease : a randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Oncology | 2014

von van Rhee, F. | Wong, R. | Munshi, N. | +19

ErratumIn: Lancet Oncol. 2014 Sep;15(10):417

85

Exploiting interleukin 6 in multicentric Castleman's disease

enthalten in: The Lancet. Oncology | 2014

von Bower, M. | Stebbing, J.

CommentOn: Lancet Oncol. 2014 Aug;15(9):966-74. - PMID 25042199

86

Green light for Janssen's IL-6 blocker

enthalten in: Nature biotechnology | 2014

von Mullard, A.

87

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects

enthalten in: Clinical pharmacology in drug development | 2014

von Xu, C. | Han, C. | Marini, J. | +9

88

Siltuximab : first global approval

enthalten in: Drugs | 2014

von Markham, A. | Patel, T.

89

Antitumor efficacy of the anti-interleukin-6 (IL-6) antibody siltuximab in mouse xenograft models of lung cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2014

von Song, L. | Smith, M. | Doshi, P. | +4

90

Siltuximab in transplant-ineligible patients with myeloma

enthalten in: The Lancet. Oncology | 2014

von Bagcchi, S.